TCL1	O
oncogene	O
activation	O
in	O
preleukemic	B-cell_type
T	I-cell_type
cells	I-cell_type
from	O
a	O
case	O
of	O
ataxia-telangiectasia	O
.	O

The	O
TCL1	B-DNA
oncogene	I-DNA
on	O
human	B-DNA
chromosome	I-DNA
14q32.1	B-DNA
is	O
involved	O
in	O
chromosome	O
translocations	O
[	O
t	B-DNA
(	I-DNA
14	I-DNA
;	I-DNA
14	I-DNA
)	I-DNA
(	I-DNA
q11	I-DNA
;	I-DNA
q32.1	I-DNA
)	I-DNA
and	O
t	B-DNA
(	I-DNA
7	I-DNA
;	I-DNA
14	I-DNA
)	I-DNA
(	I-DNA
q35	I-DNA
;	I-DNA
q32.1	I-DNA
)	I-DNA
]	O
and	O
inversions	O
[	O
inv14	B-DNA
(	I-DNA
q11	I-DNA
;	I-DNA
q32.1	I-DNA
)	I-DNA
]	O
with	O
TCR	B-DNA
alpha/beta	I-DNA
loci	I-DNA
in	O
T-cell	O
leukemias	O
,	O
such	O
as	O
T-prolymphocytic	O
(	O
T-PLL	O
)	O
.	O

It	O
is	O
also	O
involved	O
in	O
T-	O
acute	O
and-	O
chronic	O
leukemias	O
arising	O
in	O
cases	O
of	O
ataxia-telangiectasia	O
(	O
AT	O
)	O
,	O
an	O
immunodeficiency	O
syndrome	O
.	O

Similar	O
chromosomal	O
rearrangements	O
occur	O
also	O
in	O
the	O
clonally	O
expanded	O
T	B-cell_type
cells	I-cell_type
in	O
AT	O
patients	O
before	O
the	O
appearance	O
of	O
the	O
overt	O
leukemia	O
.	O

We	O
have	O
analyzed	O
the	O
expression	O
of	O
TCL1	B-RNA
mRNA	I-RNA
and	O
protein	B-protein
in	O
peripheral	B-cell_type
blood	I-cell_type
lymphocytes	I-cell_type
(	O
PBLs	B-cell_type
)	O
from	O
four	O
AT	O
cases	O
and	O
from	O
healthy	O
controls	O
.	O

We	O
found	O
that	O
the	O
TCL1	B-DNA
gene	I-DNA
was	O
overexpressed	O
in	O
the	O
PBLs	B-cell_type
of	O
an	O
AT	O
patient	O
with	O
a	O
large	B-cell_line
clonal	I-cell_line
T-cell	I-cell_line
population	I-cell_line
exhibiting	O
the	O
t	O
(	O
14	O
;	O
14	O
)	O
translocation	O
but	O
not	O
in	O
the	O
lymphocytes	B-cell_type
of	O
the	O
other	O
cases	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
of	O
the	O
TCL1	B-DNA
genomic	I-DNA
locus	I-DNA
to	O
lymphocyte	O
metaphases	O
from	O
the	O
AT	O
patient	O
with	O
the	O
T-cell	O
clonal	O
expansion	O
showed	O
that	O
the	O
breakpoint	O
of	O
the	O
t	O
(	O
14	O
;	O
14	O
)	O
translocation	O
lies	O
within	O
the	O
TCL1	B-DNA
locus	I-DNA
and	O
is	O
accompanied	O
by	O
an	O
inverted	O
duplication	O
of	O
the	O
distal	B-DNA
part	I-DNA
of	O
chromosome	B-DNA
14	I-DNA
.	O

These	O
data	O
indicate	O
that	O
TCL1	B-DNA
is	O
activated	O
in	O
preleukemic	B-cell_line
clonal	I-cell_line
cells	I-cell_line
as	O
a	O
consequence	O
of	O
chromosome	O
translocation	O
involving	O
sequences	O
from	O
the	O
TCR	B-DNA
locus	I-DNA
at	O
14q11	B-DNA
.	O

Deregulation	O
of	O
TCL1	B-DNA
is	O
the	O
first	O
event	O
in	O
the	O
initiation	O
of	O
malignancy	O
in	O
these	O
types	O
of	O
leukemias	O
and	O
represents	O
a	O
potential	O
tool	O
for	O
clinical	O
evaluation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TCL1	NULL
Oncogene	NULL
Activation	NULL
in	NULL
Preleukemic	NULL
T	NULL
Cells	NULL
From	NULL
a	NULL
Case	NULL
of	NULL
Ataxia-Telangiectasia	NULL
By	NULL
Maria	NULL
Grazia	NULL
Narducci	NULL
,	NULL
Laura	NULL
Virgilio	NULL
,	NULL
Masaharu	NULL
Isobe	NULL
,	NULL
Antonella	NULL
Stoppacciaro	NULL
,	NULL
Raffaella	NULL
Elli	NULL
,	NULL
Massimo	NULL
Fiorilli	NULL
,	NULL
Maurizio	NULL
Carbonari	NULL
,	NULL
Anna	NULL
Antonelli	NULL
,	NULL
Luciana	NULL
Chessa	NULL
,	NULL
Carlo	NULL
Maria	NULL
Croce	NULL
,	NULL
and	NULL
Giandomenico	NULL
Russo	NULL
The	NULL
TCL1	NULL
oncogene	NULL
on	NULL
human	NULL
chromosome	NULL
14q32.1	NULL
is	NULL
involved	NULL
in	NULL
chromosome	NULL
translocations	NULL
[	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
and	NULL
t	NULL
(	NULL
7	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q35	NULL
;	NULL
q32.1	NULL
)	NULL
]	NULL
and	NULL
inversions	NULL
[	NULL
inv14	NULL
(	NULL
q11	NULL
;	NULL
432.1	NULL
)	NULL
]	NULL
with	NULL
TCRa/f	NULL
loci	NULL
in	NULL
T-cell	NULL
leukemias	NULL
,	NULL
such	NULL
as	NULL
T-prolymphocytic	NULL
(	NULL
T-PLL	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
T-acute	NULL
and	NULL
-chronic	NULL
leukemias	NULL
arising	NULL
in	NULL
cases	NULL
of	NULL
ataxia-telangiectasia	NULL
(	NULL
AT	NULL
)	NULL
,	NULL
an	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

Similar	NULL
chromosomal	NULL
rearrangements	NULL
occur	NULL
also	NULL
in	NULL
the	NULL
clonally	NULL
expanded	NULL
T	NULL
cells	NULL
in	NULL
AT	NULL
patients	NULL
before	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
overt	NULL
leukemia	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
TCL1	NULL
mRNA	NULL
and	NULL
protein	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
from	NULL
four	NULL
AT	NULL
cases	NULL
and	NULL
from	NULL
healthy	NULL
controls	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
TCL1	NULL
gene	NULL
was	NULL
overexpressed	NULL
in	NULL
the	NULL
PBLs	NULL
of	NULL
an	NULL
AT	NULL
patient	NULL
with	NULL
a	NULL
large	NULL
clonal	NULL
T-cell	NULL
population	NULL
exhibiting	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
HE	NULL
DEVELOPMENT	NULL
OF	NULL
human	NULL
cancer	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
multistep	NULL
process	NULL
that	NULL
entails	NULL
a	NULL
progressively	NULL
more	NULL
aggressive	NULL
phenotype	NULL
through	NULL
the	NULL
evolution	NULL
of	NULL
cellular	NULL
subsets	NULL
with	NULL
increasing	NULL
numbers	NULL
of	NULL
genetic	NULL
alterations	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
steps	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
full	NULL
manifestation	NULL
of	NULL
the	NULL
tumor	NULL
is	NULL
currently	NULL
under	NULL
study	NULL
because	NULL
of	NULL
its	NULL
impact	NULL
on	NULL
cancer	NULL
diagnosis	NULL
and	NULL
treatment	NULL
and	NULL
for	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
malignant	NULL
process	NULL
.	NULL
``	NULL

In	NULL
hematopoietic	NULL
tumors	NULL
,	NULL
cytogenetic	NULL
alterations	NULL
such	NULL
as	NULL
chromosomal	NULL
translocations	NULL
and	NULL
inversions	NULL
are	NULL
quite	NULL
com-mon	NULL
.	NULL

These	NULL
chromosomal	NULL
aberrations	NULL
directly	NULL
involve	NULL
genes	NULL
responsible	NULL
for	NULL
malignant	NULL
transformation	NULL
,	NULL
``	NULL
but	NULL
development	NULL
of	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
is	NULL
also	NULL
a	NULL
multistep	NULL
process	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
,	NULL
for	NULL
example	NULL
,	NULL
that	NULL
follicular	NULL
lymphoma	NULL
(	NULL
a	NULL
low-grade	NULL
malignancy	NULL
)	NULL
with	NULL
BCL2	NULL
rearrangement	NULL
can	NULL
progress	NULL
to	NULL
a	NULL
more	NULL
aggressive	NULL
form	NULL
of	NULL
tumor	NULL
by	NULL
acquiring	NULL
a	NULL
c	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Raggio-Italgene	NULL
,	NULL
Pomezia	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
and	NULL
Jefferson	NULL
Cancer	NULL
Center	NULL
,	NULL
Jefferson	NULL
Medical	NULL
College	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
;	NULL
the	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
Laboratory	NULL
,	NULL
Chemical	NULL
and	NULL
Biochemical	NULL
Engineering	NULL
,	NULL
Faculty	NULL
of	NULL
Engineering	NULL
,	NULL
Toyama	NULL
University	NULL
,	NULL
Toyama	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
the	NULL
Departments	NULL
of	NULL
Human	NULL
Biopathology	NULL
,	NULL
Experimental	NULL
Medicine	NULL
,	NULL
and	NULL
Clinical	NULL
Medicine	NULL
,	NULL
University	NULL
``	NULL
La	NULL
Sa-pienza	NULL
,	NULL
``	NULL
'	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

Submitted	NULL
April	NULL
13	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
May	NULL
12	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
Grant	NULL
No	NULL
.	NULL

€A39860	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
to	NULL
C.	NULL
M.	NULL
C.	NULL
;	NULL
by	NULL
Special	NULL
Coordination	NULL
Funds	NULL
of	NULL
the	NULL
Science	NULL
Technology	NULL
Agency	NULL
of	NULL
the	NULL
Japanese	NULL
Government	NULL
,	NULL
Research	NULL
Grant	NULL
on	NULL
Aging	NULL
and	NULL
Health	NULL
;	NULL
by	NULL
a	NULL
Grant-in-Aid	NULL
for	NULL
a	NULL
Creative	NULL
Basic	NULL
Research	NULL
(	NULL
HumanGenome	NULL
Program	NULL
)	NULL
and	NULL
for	NULL
a	NULL
Cancer	NULL
Research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
Japan	NULL
to	NULL
M.	NULL
I.	NULL
;	NULL
and	NULL
by	NULL
the	NULL
CNR	NULL
progetto	NULL
finalizzato	NULL
ACRO	NULL
No	NULL
.	NULL

94.011105	NULL
.	NULL

PF39	NULL
to	NULL
L.	NULL
C.	NULL
Address	NULL
reprint	NULL
requests	NULL
to	NULL
Giandomenico	NULL
Russo	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Raggio-Itaigene	NULL
,	NULL
Via	NULL
delle	NULL
Antille	NULL
29	NULL
,	NULL
00040	NULL
Pomezia	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8606-0003	NULL
$	NULL
3.00/0	NULL
2358	NULL
but	NULL
not	NULL
in	NULL
the	NULL
lymphocytes	NULL
of	NULL
the	NULL
other	NULL
cases	NULL
.	NULL

Fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
of	NULL
the	NULL
TCL1	NULL
genomic	NULL
locus	NULL
to	NULL
lymphocyte	NULL
metaphases	NULL
from	NULL
the	NULL
AT	NULL
patient	NULL
with	NULL
the	NULL
T-cell	NULL
clonal	NULL
expansion	NULL
showed	NULL
that	NULL
the	NULL
breakpoint	NULL
of	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
lies	NULL
within	NULL
the	NULL
TCL1	NULL
locus	NULL
and	NULL
is	NULL
accompanied	NULL
by	NULL
an	NULL
inverted	NULL
duplication	NULL
of	NULL
the	NULL
distal	NULL
part	NULL
of	NULL
chromosome	NULL
14	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
TCL1	NULL
is	NULL
activated	NULL
in	NULL
preleukemic	NULL
clonal	NULL
cells	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
chromosome	NULL
translocation	NULL
involving	NULL
sequences	NULL
from	NULL
the	NULL
TCR	NULL
locus	NULL
at	NULL
14q11	NULL
.	NULL

Deregulation	NULL
of	NULL
TCL1	NULL
is	NULL
the	NULL
first	NULL
event	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
malignancy	NULL
in	NULL
these	NULL
types	NULL
of	NULL
leukemias	NULL
and	NULL
represents	NULL
a	NULL
potential	NULL
tool	NULL
for	NULL
clinical	NULL
evaluation	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

MYC	NULL
gene	NULL
rearrangement	NULL
;	NULL
another	NULL
example	NULL
is	NULL
the	NULL
clinical	NULL
transition	NULL
from	NULL
chronic	NULL
to	NULL
acute	NULL
phase	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
in	NULL
which	NULL
p53	NULL
mutations	NULL
and	NULL
deletions	NULL
are	NULL
observed	NULL
in	NULL
20	NULL
%	NULL
to	NULL
30	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
of	NULL
blastic	NULL
crisis	NULL
.	NULL
``	NULL

An	NULL
excellent	NULL
model	NULL
for	NULL
studying	NULL
tumor	NULL
progression	NULL
is	NULL
represented	NULL
by	NULL
T-cell	NULL
leukemias	NULL
arising	NULL
in	NULL
patients	NULL
with	NULL
ataxia-telangiectasia	NULL
(	NULL
AT	NULL
)	NULL
,	NULL
an	NULL
immunodeficiency	NULL
syndrome	NULL
associated	NULL
with	NULL
genomic	NULL
instability	NULL
,	NULL
deficient	NULL
DNA	NULL
repair	NULL
,	NULL
cerebellar	NULL
ataxia	NULL
,	NULL
and	NULL
oculocutaneous	NULL
telangiectasias	NULL
.	NULL

These	NULL
patients	NULL
are	NULL
prone	NULL
to	NULL
cancer	NULL
(	NULL
10	NULL
%	NULL
)	NULL
,	NULL
especially	NULL
of	NULL
the	NULL
hematopoietic	NULL
lineage	NULL
,	NULL
with	NULL
a	NULL
70-	NULL
to	NULL
250-fold	NULL
increase	NULL
in	NULL
the	NULL
probability	NULL
of	NULL
developing	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
,	NULL
particularly	NULL
in	NULL
childhood	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
general	NULL
popula-tion	NULL
,	NULL
in	NULL
which	NULL
B-cell	NULL
leukemias	NULL
are	NULL
predominant	NULL
,	NULL
leukemias	NULL
of	NULL
T-cell	NULL
phenotype	NULL
are	NULL
particularly	NULL
frequent	NULL
in	NULL
the	NULL
AT	NULL
population	NULL
.	NULL

In	NULL
these	NULL
patients	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
clonal	NULL
T-cell	NULL
expansions	NULL
has	NULL
been	NULL
observed	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
full-blown	NULL
leukemia	NULL
(	NULL
reviewed	NULL
by	NULL
Kirsh®	NULL
)	NULL
.	NULL

These	NULL
expansions	NULL
are	NULL
of	NULL
two	NULL
types	NULL
.	NULL

The	NULL
first	NULL
type	NULL
of	NULL
expansions	NULL
is	NULL
characterized	NULL
by	NULL
translocations	NULL
and	NULL
inversions	NULL
[	NULL
t	NULL
(	NULL
7	NULL
;	NULL
7	NULL
)	NULL
(	NULL
p15	NULL
;	NULL
q35	NULL
)	NULL
,	NULL
inv	NULL
7	NULL
(	NULL
p15	NULL
;	NULL
q435	NULL
)	NULL
,	NULL
t	NULL
(	NULL
7	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q35	NULL
;	NULL
q11	NULL
)	NULL
,	NULL
and	NULL
t	NULL
(	NULL
7	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p15	NULL
;	NULL
q11	NULL
)	NULL
]	NULL
that	NULL
usually	NULL
involve	NULL
rearrangements	NULL
among	NULL
T-cell	NULL
receptor	NULL
genes	NULL
'	NULL
and	NULL
are	NULL
not	NULL
associated	NULL
with	NULL
neoplasia	NULL
.	NULL

The	NULL
second	NULL
type	NULL
of	NULL
expansions	NULL
,	NULL
which	NULL
is	NULL
observed	NULL
in	NULL
7	NULL
%	NULL
of	NULL
10	NULL
%	NULL
of	NULL
all	NULL
AT	NULL
cases	NULL
,	NULL
``	NULL
involves	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
cells	NULL
carrying	NULL
either	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q1	NULL
1	NULL
;	NULL
32.1	NULL
)	NULL
translocation	NULL
or	NULL
inv	NULL
14	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
inver-sion	NULL
,	NULL
or	NULL
more	NULL
rarely	NULL
t	NULL
(	NULL
X	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q28	NULL
;	NULL
q11	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
cells	NULL
tend	NULL
to	NULL
expand	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
with	NULL
time	NULL
until	NULL
they	NULL
represent	NULL
90	NULL
%	NULL
to	NULL
100	NULL
%	NULL
of	NULL
all	NULL
circulating	NULL
lymphocytes	NULL
and	NULL
invariably	NULL
progress	NULL
to	NULL
a	NULL
frank	NULL
leukemia	NULL
.	NULL
``	NULL

Chromosomal	NULL
translocations	NULL
in	NULL
the	NULL
latter	NULL
cases	NULL
involve	NULL
on	NULL
one	NULL
side	NULL
the	NULL
TCRa	NULL
locus	NULL
on	NULL
chromosome	NULL
14q11	NULL
and	NULL
,	NULL
on	NULL
the	NULL
other	NULL
side	NULL
,	NULL
either	NULL
the	NULL
TCL1	NULL
gene	NULL
on	NULL
14q32.1	NULL
``	NULL
or	NULL
the	NULL
MTCP1/	NULL
6.1b	NULL
gene	NULL
on	NULL
Xq28	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
These	NULL
two	NULL
genes	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
and	NULL
,	NULL
interestingly	NULL
,	NULL
show	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
to	NULL
each	NULL
other	NULL
.	NULL
``	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
TCL1	NULL
gene	NULL
is	NULL
normally	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
cases	NULL
of	NULL
T-prolymphocytic	NULL
leukemia	NULL
(	NULL
T-PLL	NULL
)	NULL
,	NULL
a	NULL
very	NULL
aggressive	NULL
type	NULL
of	NULL
mature	NULL
T-cell	NULL
proliferation	NULL
accompanied	NULL
by	NULL
rearrangements	NULL
at	NULL
14q32	NULL
in	NULL
80	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
Interestingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
some	NULL
of	NULL
the	NULL
full-blown	NULL
leukemias	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
6	NULL
(	NULL
September	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
2358-2364	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TCL1	NULL
ACTIVATION	NULL
IN	NULL
PRELEUKEMIC	NULL
T	NULL
CELLS	NULL
arising	NULL
in	NULL
AT	NULL
or	NULL
,	NULL
in	NULL
one	NULL
case	NULL
,	NULL
a	NULL
preleukemic	NULL
clonal	NULL
expansion	NULL
have	NULL
morphologic	NULL
features	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
T-PLLs	NULL
.	NULL
``	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
and	NULL
gene	NULL
product	NULL
in	NULL
clonal	NULL
AT	NULL
expansions	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
peripheral	NULL
blood	NULL
cells	NULL
from	NULL
an	NULL
AT	NULL
case	NULL
exhibiting	NULL
a	NULL
clonal	NULL
expansion	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
60	NULL
%	NULL
of	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
[	NULL
PBLs	NULL
]	NULL
)	NULL
with	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
chromosome	NULL
translocation	NULL
.	NULL

Comparison	NULL
of	NULL
these	NULL
PBLs	NULL
to	NULL
PBL	NULL
s	NULL
derived	NULL
from	NULL
three	NULL
other	NULL
AT	NULL
patients	NULL
without	NULL
cytogenetic	NULL
evidence	NULL
of	NULL
clonal	NULL
expansion	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
and	NULL
with	NULL
a	NULL
normal	NULL
healthy	NULL
control	NULL
shows	NULL
that	NULL
TCL1	NULL
gene	NULL
is	NULL
deregulated	NULL
only	NULL
in	NULL
the	NULL
preleukemic	NULL
cells	NULL
carrying	NULL
the	NULL
chromosomal	NULL
translocation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patient	NULL
samples	NULL
and	NULL
purification	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

-	NULL
Lymphocytes	NULL
from	NULL
four	NULL
patients	NULL
with	NULL
AT	NULL
and	NULL
a	NULL
healthy	NULL
donor	NULL
were	NULL
analyzed	NULL
in	NULL
this	NULL
study	NULL
.	NULL

AT94-1	NULL
is	NULL
a	NULL
16-year-old	NULL
girl	NULL
with	NULL
classical	NULL
AT	NULL
.	NULL

The	NULL
first	NULL
karyotypic	NULL
analysis	NULL
of	NULL
her	NULL
lymphocytes	NULL
was	NULL
performed	NULL
in	NULL
1986	NULL
and	NULL
showed	NULL
4	NULL
%	NULL
clonal	NULL
cells	NULL
carrying	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
.	NULL

This	NULL
abnormality	NULL
increased	NULL
to	NULL
60	NULL
%	NULL
and	NULL
has	NULL
remained	NULL
stable	NULL
at	NULL
this	NULL
frequency	NULL
in	NULL
the	NULL
last	NULL
two	NULL
semiannual	NULL
observations	NULL
.	NULL
``	NULL

The	NULL
white	NULL
blood	NULL
cell	NULL
count	NULL
was	NULL
6,220/mL	NULL
,	NULL
with	NULL
lymphocytes	NULL
ranging	NULL
around	NULL
14.4	NULL
%	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
her	NULL
PBLs	NULL
at	NULL
the	NULL
time	NULL
of	NULL
the	NULL
last	NULL
observation	NULL
was	NULL
the	NULL
following	NULL
:	NULL
CD45*CD3*	NULL
(	NULL
65	NULL
%	NULL
)	NULL
,	NULL
CD45*CD20®	NULL
(	NULL
11	NULL
%	NULL
)	NULL
,	NULL
(	NULL
61	NULL
%	NULL
)	NULL
,	NULL
TCRy/6	NULL
(	NULL
3	NULL
%	NULL
)	NULL
,	NULL
CD4*	NULL
(	NULL
49	NULL
%	NULL
)	NULL
,	NULL
CD8*	NULL
(	NULL
17	NULL
%	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
AT94-1	NULL
and	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
enriched	NULL
by	NULL
adhering	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
to	NULL
a	NULL
nylon-wool	NULL
column	NULL
at	NULL
37°C	NULL
for	NULL
60	NULL
minutes	NULL
and	NULL
T-enriched	NULL
celis	NULL
were	NULL
collected	NULL
in	NULL
the	NULL
eluted	NULL
fraction	NULL
.	NULL

After	NULL
purification	NULL
,	NULL
T	NULL
cells	NULL
from	NULL
normal	NULL
control	NULL
and	NULL
AT94-1	NULL
represented	NULL
approximately	NULL
77	NULL
%	NULL
,	NULL
with	NULL
the	NULL
remaining	NULL
cells	NULL
being	NULL
CD3~-CD56*	NULL
(	NULL
natural	NULL
killer	NULL
cells	NULL
)	NULL
and	NULL
less	NULL
than	NULL
1	NULL
%	NULL
being	NULL
CD19*	NULL
(	NULL
B	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
other	NULL
three	NULL
patients	NULL
were	NULL
classical	NULL
AT	NULL
cases	NULL
without	NULL
cytogenetically	NULL
evident	NULL
clonal	NULL
expansions	NULL
.	NULL

Cytogenetics	NULL
and	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
.	NULL

Chromosome	NULL
preparations	NULL
were	NULL
obtained	NULL
using	NULL
standard	NULL
methods	NULL
from	NULL
72-hour	NULL
lymphocyte	NULL
phytohemagglutinin-stimulated	NULL
cultures	NULL
of	NULL
AT	NULL
patients	NULL
.	NULL

Analysis	NULL
of	NULL
spontaneous	NULL
chromosome	NULL
rearrangements	NULL
was	NULL
performed	NULL
on	NULL
at	NULL
least	NULL
30	NULL
G-banded	NULL
metaphases	NULL
.	NULL

For	NULL
FISH	NULL
analysis	NULL
,	NULL
the	NULL
cosmid	NULL
clones	NULL
pPLC-1	NULL
and	NULL
pPLC-4	NULL
were	NULL
isolated	NULL
by	NULL
screening	NULL
a	NULL
human	NULL
placental	NULL
genomic	NULL
library	NULL
using	NULL
probes	NULL
BO.9	NULL
and	NULL
pE/S	NULL
.	NULL
``	NULL

''	NULL
The	NULL
pPLC-4	NULL
cosmid	NULL
contains	NULL
a	NULL
genomic	NULL
fragment	NULL
corresponding	NULL
to	NULL
the	NULL
region	NULL
from	NULL
pE/S	NULL
to	NULL
the	NULL
region	NULL
40	NULL
kb	NULL
centromeric	NULL
to	NULL
pE/S	NULL
(	NULL
Fig	NULL
1D	NULL
)	NULL
.	NULL

The	NULL
TCL1	NULL
gene	NULL
,	NULL
and	NULL
pPLC-1	NULL
cosmid	NULL
are	NULL
located	NULL
about	NULL
120	NULL
and	NULL
250	NULL
kb	NULL
centromeric	NULL
to	NULL
the	NULL
end	NULL
of	NULL
the	NULL
pPLC-4	NULL
cosmid	NULL
,	NULL
respectively	NULL
.	NULL
'	NULL

''	NULL
For	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
pPLC-1	NULL
or	NULL
pPLC-4	NULL
was	NULL
labeled	NULL
with	NULL
biotin-16-dUTP	NULL
or	NULL
digoxigenin-1	NULL
1-dUTP	NULL
,	NULL
respectively	NULL
,	NULL
using	NULL
a	NULL
nick-translation	NULL
kit	NULL
(	NULL
Bethesda	NULL
Research	NULL
Labora-tories	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

The	NULL
hybridization	NULL
mixture	NULL
contained	NULL
200	NULL
ng	NULL
each	NULL
of	NULL
both	NULL
labeled	NULL
probes	NULL
,	NULL
pPLC-1	NULL
and	NULL
pPLC-4	NULL
,	NULL
as	NULL
well	NULL
as	NULL
10	NULL
ug	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
Escherichia	NULL
coli	NULL
tRNA	NULL
,	NULL
and	NULL
350	NULL
ng	NULL
of	NULL
human	NULL
Cot-1	NULL
DNA	NULL
(	NULL
Bethesda	NULL
Research	NULL
Labo-ratory	NULL
)	NULL
in	NULL
10	NULL
gL	NULL
of	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
50	NULL
mmol/L	NULL
phosphate	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
pH	NULL
7.0	NULL
.	NULL

Before	NULL
hybridization	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
denatured	NULL
at	NULL
75°C	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
quickly	NULL
chilled	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
minutes	NULL
to	NULL
compete	NULL
for	NULL
repetitive	NULL
sequences	NULL
in	NULL
the	NULL
probe	NULL
.	NULL

After	NULL
overnight	NULL
hybridization	NULL
,	NULL
the	NULL
slides	NULL
were	NULL
washed	NULL
for	NULL
20	NULL
minutes	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
at	NULL
37°C	NULL
,	NULL
followed	NULL
by	NULL
two	NULL
15-minute	NULL
washes	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
and	NULL
finally	NULL
rinsed	NULL
in	NULL
4	NULL
%	NULL
SSC	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
avidin	NULL
and	NULL
antidigoxigenin	NULL
tagged	NULL
with	NULL
rhodamine	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
were	NULL
used	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
biotinylated	NULL
pPLC-1	NULL
and	NULL
digoxigenin-labeled	NULL
pPLC-4	NULL
.	NULL

The	NULL
chromo-	NULL
2359	NULL
somes	NULL
were	NULL
counter-stained	NULL
with	NULL
0.1	NULL
pg/mL	NULL
of	NULL
Hoechst	NULL
33258	NULL
DNA	NULL
dye	NULL
.	NULL

RNA	NULL
extraction	NULL
.	NULL

A	NULL
total	NULL
of	NULL
7	NULL
to	NULL
10	NULL
mL	NULL
of	NULL
venous	NULL
blood	NULL
was	NULL
obtained	NULL
by	NULL
standard	NULL
venipuncture	NULL
techniques	NULL
using	NULL
heparinazed	NULL
tubes	NULL
,	NULL
mixed	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
RPMI	NULL
medium	NULL
,	NULL
and	NULL
then	NULL
layered	NULL
over	NULL
8	NULL
mL	NULL
of	NULL
Ficoll	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
in	NULL
a	NULL
50-mL	NULL
polystyrene	NULL
tube.The	NULL
gradient	NULL
was	NULL
centrifuged	NULL
at	NULL
800g	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
lymphomonocyte	NULL
layer	NULL
was	NULL
collected	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
RPMI	NULL
medium	NULL
and	NULL
then	NULL
sedimented	NULL
at	NULL
300g	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
discarded	NULL
and	NULL
the	NULL
pellet	NULL
containing	NULL
nucleated	NULL
cells	NULL
was	NULL
used	NULL
for	NULL
RNA	NULL
extraction	NULL
using	NULL
the	NULL
RNAzol	NULL
B	NULL
method	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Tel-Test	NULL
,	NULL
Inc	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Semiquantitave	NULL
reverse	NULL
transcriptase-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
.	NULL

-	NULL
cDNA	NULL
was	NULL
made	NULL
from	NULL
total	NULL
RNA	NULL
using	NULL
random	NULL
primer	NULL
oligonucleotides	NULL
.	NULL

Approximately	NULL
0.5	NULL
ug	NULL
of	NULL
RNA	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
35	NULL
uL	NULL
was	NULL
first	NULL
denatured	NULL
at	NULL
80°C	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
then	NULL
cooled	NULL
on	NULL
ice	NULL
.	NULL

First-strand	NULL
DNA	NULL
synthesis	NULL
was	NULL
performed	NULL
by	NULL
adding	NULL
1	NULL
pL	NULL
of	NULL
Superscript	NULL
Reverse	NULL
Transcriptase	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
100	NULL
mmol/L	NULL
ditiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
10	NULL
%	NULL
RT	NULL
buffer	NULL
,	NULL
40	NULL
pmol/L	NULL
of	NULL
random	NULL
primers	NULL
,	NULL
40	NULL
pmol/L	NULL
dRPN6	NULL
(	NULL
Boheringer	NULL
Mannheim	NULL
)	NULL
,	NULL
10	NULL
mmol/L	NULL
of	NULL
dNTP	NULL
,	NULL
and	NULL
36	NULL
U	NULL
of	NULL
RNAse	NULL
block	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
uL	NULL
.	NULL

For	NULL
monitoring	NULL
the	NULL
cDNA	NULL
synthesis	NULL
,	NULL
5	NULL
gL	NULL
of	NULL
this	NULL
reaction	NULL
was	NULL
removed	NULL
at	NULL
the	NULL
beginning	NULL
of	NULL
the	NULL
synthesis	NULL
and	NULL
5	NULL
uCi	NULL
of	NULL
a	NULL
``	NULL
Phospho-rus	NULL
dATP	NULL
(	NULL
800	NULL
mCi/mL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

The	NULL
two	NULL
reactions	NULL
(	NULL
radiolabeled	NULL
and	NULL
not	NULL
radiolabeled	NULL
)	NULL
were	NULL
left	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
hour	NULL
;	NULL
the	NULL
two	NULL
cDNAs	NULL
were	NULL
then	NULL
boiled	NULL
for	NULL
5	NULL
minutes	NULL
or	NULL
kept	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
-70°C	NULL
for	NULL
further	NULL
use	NULL
.	NULL

The	NULL
radioactive	NULL
fraction	NULL
was	NULL
purified	NULL
through	NULL
Sephadex	NULL
Nick	NULL
Spin	NULL
Columns	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
then	NULL
counted	NULL
on	NULL
a	NULL
/3	NULL
scintillation	NULL
counter	NULL
(	NULL
Packard	NULL
,	NULL
Downers	NULL
Grove	NULL
,	NULL
IL	NULL
)	NULL
to	NULL
evaluate	NULL
the	NULL
cDNA	NULL
synthesis	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
of	NULL
nonradioactive	NULL
cDNAs	NULL
was	NULL
then	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
.	NULL

All	NULL
the	NULL
cDNA	NULL
samples	NULL
in	NULL
Fig	NULL
2	NULL
were	NULL
synthetized	NULL
and	NULL
used	NULL
for	NULL
PCR	NULL
amplification	NULL
in	NULL
the	NULL
same	NULL
set	NULL
of	NULL
experiments	NULL
to	NULL
minimize	NULL
the	NULL
variations	NULL
.	NULL

The	NULL
primers	NULL
used	NULL
for	NULL
amplification	NULL
of	NULL
a	NULL
306-bp	NULL
product	NULL
of	NULL
the	NULL
TCL1	NULL
transcript	NULL
by	NULL
PCR	NULL
were	NULL
TCL1-U1	NULL
(	NULL
5AGGCCTATGACCCC-CACC3	NULL
'	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
+	NULL
strand	NULL
from	NULL
bp	NULL
232-249	NULL
,	NULL
and	NULL
TCLI-R2	NULL
(	NULL
SCATTCCTCCCAGACCCCA3	NULL
'	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
-strand	NULL
from	NULL
bp	NULL
511-529	NULL
of	NULL
the	NULL
TCL1	NULL
.	NULL

Primers	NULL
specific	NULL
for	NULL
amplification	NULL
of	NULL
a	NULL
154-bp	NULL
product	NULL
of	NULL
the	NULL
housekeeping	NULL
B-actin	NULL
gene	NULL
were	NULL
A1	NULL
(	NULL
5TCATCACCATTGGCAAT-GAG3	NULL
'	NULL
)	NULL
and	NULL
A2	NULL
(	NULL
5GTGTTGGCGTACAGGT3	NULL
'	NULL
)	NULL
.	NULL

PCR	NULL
and	NULL
amplification	NULL
were	NULL
performed	NULL
under	NULL
the	NULL
following	NULL
conditions	NULL
:	NULL
denaturing	NULL
for	NULL
1	NULL
minute	NULL
at	NULL
94°C	NULL
,	NULL
annealing	NULL
for	NULL
1	NULL
minute	NULL
at	NULL
60°C	NULL
,	NULL
and	NULL
elongation	NULL
for	NULL
1	NULL
minute	NULL
at	NULL
72°C	NULL
for	NULL
25	NULL
cycles	NULL
(	NULL
TCL1	NULL
)	NULL
or	NULL
15	NULL
cycles	NULL
(	NULL
G-actin	NULL
)	NULL
.	NULL

Immunostaining	NULL
.	NULL

-	NULL
Immunohistochemistry	NULL
was	NULL
performed	NULL
on	NULL
cytospins	NULL
of	NULL
T-cell-enriched	NULL
PBLs	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
fixed	NULL
in	NULL
100	NULL
%	NULL
acetone	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
dried	NULL
,	NULL
postfixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
immunostained	NULL
with	NULL
optimal	NULL
dilutions	NULL
of	NULL
anti-TCL1	NULL
polyclonal	NULL
rabbit	NULL
antiserum	NULL
and	NULL
mouse	NULL
monoclonal	NULL
anti-CD7	NULL
,	NULL
-CD19	NULL
,	NULL
and	NULL
-CD68	NULL
.	NULL

Cytospins	NULL
were	NULL
preincubated	NULL
with	NULL
goat	NULL
antiserum	NULL
or	NULL
rabbit	NULL
serum	NULL
and	NULL
sequentially	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
,	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
,	NULL
rabbit	NULL
antimouse	NULL
IgG	NULL
,	NULL
rabbit	NULL
antiperoxidase	NULL
(	NULL
PAP	NULL
)	NULL
,	NULL
or	NULL
mouse	NULL
peroxidase	NULL
antiperoxidase	NULL
.	NULL

Each	NULL
incubation	NULL
step	NULL
lasted	NULL
30	NULL
minutes	NULL
and	NULL
was	NULL
followed	NULL
by	NULL
10	NULL
minutes	NULL
of	NULL
washing	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
0.03	NULL
%	NULL
H	NULL
;	NULL
O	NULL
;	NULL
and	NULL
0.06	NULL
%	NULL
3	NULL
,	NULL
3'-diaminobenzidine	NULL
for	NULL
2	NULL
to	NULL
5	NULL
minutes	NULL
,	NULL
washed	NULL
in	NULL
tap	NULL
water	NULL
,	NULL
and	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
.	NULL

The	NULL
number	NULL
of	NULL
positive	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
light	NULL
microscopy	NULL
at	NULL
400	NULL
%	NULL
magnification	NULL
in	NULL
five	NULL
fields	NULL
and	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

RESULTS	NULL
Cytogenetic	NULL
analysis	NULL
of	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
breakpoint	NULL
.	NULL

The	NULL
cytogenetic	NULL
analysis	NULL
by	NULL
chromosome	NULL
banding	NULL
performed	NULL
on	NULL
From	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

2360	NULL
NARDUCCI	NULL
ET	NULL
AL	NULL
pPLC-1	NULL
|	NULL
TCL1	NULL
]	NULL
40	NULL
kb	NULL
pPLC-4	NULL
|	NULL
F	NULL
¢	NULL
pPLC-1	NULL
Area	NULL
involved	NULL
in	NULL
the	NULL
4A	NULL
19°	NULL
\em	NULL
pPLC-4	NULL
inverted	NULL
duplication	NULL
«	NULL
ell	NULL
|	NULL
prics	NULL
144111	NULL
'	NULL
J	NULL
Fig	NULL
1	NULL
.	NULL

_	NULL
In	NULL
situ	NULL
hybridization	NULL
of	NULL
cosmids	NULL
clones	NULL
(	NULL
pPLC-1	NULL
and	NULL
pPLC-4	NULL
)	NULL
flanking	NULL
the	NULL
TCL-1	NULL
locus	NULL
derived	NULL
from	NULL
AT	NULL
94-1	NULL
.	NULL

The	NULL
same	NULL
chromosome	NULL
is	NULL
stained	NULL
with	NULL
the	NULL
probes	NULL
pPLC-1	NULL
(	NULL
A	NULL
)	NULL
,	NULL
pPLC-4	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
both	NULL
pPLC1	NULL
and	NULL
pPLC4	NULL
(	NULL
C	NULL
)	NULL
or	NULL
were	NULL
stained	NULL
with	NULL
Hoechst	NULL
33258	NULL
DNA	NULL
dye	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
large	NULL
arrows	NULL
and	NULL
the	NULL
triangle	NULL
represent	NULL
the	NULL
position	NULL
of	NULL
each	NULL
signal	NULL
.	NULL

(	NULL
E	NULL
)	NULL
A	NULL
schematic	NULL
representation	NULL
of	NULL
this	NULL
complex	NULL
re	NULL
arrangement	NULL
.	NULL

The	NULL
large	NULL
arrows	NULL
and	NULL
the	NULL
triangle	NULL
represent	NULL
the	NULL
signals	NULL
illustrated	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
dotted	NULL
line	NULL
is	NULL
the	NULL
breakpoint	NULL
between	NULL
14q32	NULL
and	NULL
14q11	NULL
derived	NULL
from	NULL
the	NULL
other	NULL
14	NULL
allele	NULL
.	NULL

The	NULL
double	NULL
arrow	NULL
shows	NULL
the	NULL
extension	NULL
of	NULL
the	NULL
PLC-1	NULL
area	NULL
probably	NULL
involved	NULL
by	NULL
the	NULL
inverted	NULL
duplication	NULL
.	NULL

On	NULL
the	NULL
upper	NULL
left	NULL
,	NULL
the	NULL
germline	NULL
BPLC-d	NULL
'	NULL
map	NULL
of	NULL
the	NULL
TCL1	NULL
locus	NULL
is	NULL
given	NULL
with	NULL
the	NULL
relative	NULL
position	NULL
of	NULL
the	NULL
probes	NULL
pPLC1	NULL
and	NULL
pPLC4	NULL
and	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
.	NULL

E	NULL
14932	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TCL1	NULL
ACTIVATION	NULL
IN	NULL
PRELEUKEMIC	NULL
T	NULL
CELLS	NULL
``	NULL
1	NULL
S	NULL
-	NULL
o	NULL
e	NULL
oa	NULL
-	NULL
<	NULL
Fig	NULL
2	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
.	NULL

the	NULL
lymphocytes	NULL
of	NULL
case	NULL
AT94-1	NULL
shows	NULL
that	NULL
51	NULL
of	NULL
84	NULL
(	NULL
60	NULL
%	NULL
)	NULL
metaphases	NULL
analyzed	NULL
carried	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
chromosomal	NULL
translocation	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
metaphases	NULL
(	NULL
34/51	NULL
)	NULL
showed	NULL
that	NULL
this	NULL
translocation	NULL
was	NULL
the	NULL
only	NULL
evident	NULL
cytogenetic	NULL
abnormal-ity	NULL
;	NULL
in	NULL
the	NULL
remaining	NULL
17	NULL
metaphases	NULL
additional	NULL
rearrangements	NULL
were	NULL
also	NULL
observed	NULL
:	NULL
two	NULL
subclones	NULL
were	NULL
defined	NULL
by	NULL
an	NULL
iso	NULL
(	NULL
21q	NULL
)	NULL
chromosome	NULL
(	NULL
4/51	NULL
)	NULL
and	NULL
by	NULL
a	NULL
supernumerary	NULL
C-like	NULL
chromosome	NULL
(	NULL
4/51	NULL
)	NULL
,	NULL
presumably	NULL
derived	NULL
from	NULL
a	NULL
rearranged	NULL
chromosome	NULL
22	NULL
.	NULL

No	NULL
evident	NULL
clonal	NULL
populations	NULL
with	NULL
rearrangements	NULL
at	NULL
14q32	NULL
were	NULL
observed	NULL
in	NULL
lymphocytes	NULL
of	NULL
the	NULL
other	NULL
AT	NULL
cases	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
in	NULL
AT	NULL
94-1	NULL
lymphocytes	NULL
the	NULL
DNA	NULL
joined	NULL
at	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
breakpoint	NULL
involved	NULL
the	NULL
TCL1	NULL
locus	NULL
,	NULL
we	NULL
conducted	NULL
FISH	NULL
analysis	NULL
using	NULL
probes	NULL
close	NULL
to	NULL
the	NULL
TCL1	NULL
breakpoint	NULL
.	NULL

Two	NULL
cosmid	NULL
clones	NULL
,	NULL
pPLC-1	NULL
,	NULL
localized	NULL
about	NULL
120	NULL
kb	NULL
centromeric	NULL
to	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
and	NULL
pPLC-4	NULL
,	NULL
localized	NULL
about	NULL
250	NULL
kb	NULL
telomeric	NULL
to	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
were	NULL
used	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
biotinylated	NULL
cosmid	NULL
pPLC-1	NULL
and	NULL
digoxigenin-labeled	NULL
pPLC-4	NULL
were	NULL
simultaneously	NULL
hybridized	NULL
to	NULL
AT	NULL
lymphocyte	NULL
metaphases	NULL
.	NULL

The	NULL
signals	NULL
from	NULL
pPLC-1	NULL
and	NULL
pPLC-4	NULL
were	NULL
visualized	NULL
using	NULL
FITC-conjugated	NULL
streptavidin-and	NULL
rhoda-mine-conjugated	NULL
antidigoxigenin	NULL
antibody	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
results	NULL
of	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
hybridization	NULL
of	NULL
the	NULL
pPLC-1	NULL
probe	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
peaks	NULL
of	NULL
hybridization	NULL
on	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
chromosome	NULL
[	NULL
one	NULL
located	NULL
slightly	NULL
centromeric	NULL
to	NULL
the	NULL
translocation	NULL
breakpoint	NULL
and	NULL
the	NULL
other	NULL
located	NULL
on	NULL
the	NULL
tip	NULL
of	NULL
long	NULL
arm	NULL
of	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
;	NULL
Fig	NULL
1A	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
signal	NULL
of	NULL
pPLC4	NULL
showed	NULL
three	NULL
peaks	NULL
of	NULL
hybridization	NULL
(	NULL
one	NULL
slightly	NULL
centromeric	NULL
to	NULL
the	NULL
breakpoint	NULL
,	NULL
one	NULL
at	NULL
the	NULL
breakpoint	NULL
site	NULL
,	NULL
and	NULL
the	NULL
third	NULL
at	NULL
the	NULL
tip	NULL
of	NULL
the	NULL
der	NULL
14	NULL
;	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
this	NULL
rearrengement	NULL
involves	NULL
the	NULL
TCL1	NULL
locus	NULL
splitting	NULL
the	NULL
two	NULL
probes	NULL
,	NULL
pPLC-1	NULL
and	NULL
pPLC4	NULL
,	NULL
at	NULL
the	NULL
breakpoint	NULL
site	NULL
;	NULL
furthermore	NULL
,	NULL
the	NULL
orientation	NULL
of	NULL
the	NULL
pPLC1	NULL
and	NULL
pPLC4	NULL
at	NULL
the	NULL
junction	NULL
is	NULL
inverted	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
germline	NULL
position	NULL
(	NULL
Fig	NULL
1E	NULL
)	NULL
,	NULL
because	NULL
pPLC-4	NULL
localized	NULL
telomeric	NULL
to	NULL
both	NULL
TCL1	NULL
and	NULL
pPLC-1	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
an	NULL
inversion	NULL
duplication	NULL
event	NULL
had	NULL
also	NULL
occurred	NULL
in	NULL
this	NULL
chromosome	NULL
.	NULL

As	NULL
we	NULL
have	NULL
already	NULL
desribed	NULL
,	NULL
'*	NULL
this	NULL
translocation	NULL
,	NULL
accompanied	NULL
by	NULL
an	NULL
inverted	NULL
duplication	NULL
,	NULL
will	NULL
behave	NULL
,	NULL
in	NULL
terms	NULL
of	NULL
2361	NULL
ATI	NULL
AT2	NULL
AT3	NULL
TCL1	NULL
B	NULL
-actin	NULL
juxtaposition	NULL
of	NULL
TCR	NULL
elements	NULL
(	NULL
14q11	NULL
)	NULL
to	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32.1	NULL
)	NULL
chromosome	NULL
inversions	NULL
.	NULL

This	NULL
inverted	NULL
duplication	NULL
event	NULL
seems	NULL
to	NULL
be	NULL
quite	NULL
frequent	NULL
on	NULL
T-cell	NULL
preleukemic	NULL
and	NULL
malignant	NULL
clones	NULL
,	NULL
with	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
in	NULL
AT	NULL
cases	NULL
,	NULL
``	NULL
``	NULL
and	NULL
could	NULL
result	NULL
from	NULL
chromosomal	NULL
instabilty	NULL
underlying	NULL
the	NULL
primary	NULL
defect	NULL
of	NULL
AT	NULL
.	NULL

TCLL	NULL
expression	NULL
in	NULL
AT	NULL
and	NULL
normal	NULL
lymphocytes	NULL
.	NULL

Because	NULL
the	NULL
14q32.1	NULL
breakpoint	NULL
of	NULL
case	NULL
AT94-1	NULL
was	NULL
,	NULL
as	NULL
ex-pected	NULL
,	NULL
in	NULL
the	NULL
TCL1	NULL
locus	NULL
,	NULL
we	NULL
investigated	NULL
TCL1	NULL
expression	NULL
in	NULL
cells	NULL
from	NULL
this	NULL
case	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
expression	NULL
was	NULL
altered	NULL
from	NULL
that	NULL
seen	NULL
in	NULL
normal	NULL
PBLs	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
performed	NULL
semiquantitative	NULL
PCR	NULL
amplification	NULL
of	NULL
re-verse-transcribed	NULL
mRNAs	NULL
derived	NULL
from	NULL
lymphocytes	NULL
of	NULL
AT	NULL
94-1	NULL
,	NULL
from	NULL
three	NULL
other	NULL
AT	NULL
cases	NULL
without	NULL
apparent	NULL
clonal	NULL
cells	NULL
harboring	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
,	NULL
and	NULL
from	NULL
the	NULL
Daudi	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
TCL1	NULL
protein	NULL
.	NULL
``	NULL

Reverse	NULL
transcripts	NULL
derived	NULL
from	NULL
RNAs	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
normalized	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
TCL1	NULL
and	NULL
B-actin	NULL
primers	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
the	NULL
level	NULL
of	NULL
TCL1	NULL
expression	NULL
in	NULL
AT	NULL
94-1	NULL
cells	NULL
is	NULL
much	NULL
higher	NULL
that	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
TCL1	NULL
mRNA	NULL
observed	NULL
in	NULL
the	NULL
other	NULL
three	NULL
cases	NULL
of	NULL
AT	NULL
.	NULL

cDNAs	NULL
derived	NULL
from	NULL
three	NULL
healthy	NULL
donors	NULL
expressed	NULL
levels	NULL
of	NULL
TCL1	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
the	NULL
latter	NULL
three	NULL
AT	NULL
cases	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
B-actin	NULL
was	NULL
also	NULL
used	NULL
for	NULL
further	NULL
control	NULL
.	NULL

3-Actin	NULL
was	NULL
amplified	NULL
from	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
cDNA	NULL
template	NULL
used	NULL
for	NULL
TCL1	NULL
amplification	NULL
independently	NULL
for	NULL
10	NULL
,	NULL
15	NULL
,	NULL
or	NULL
20	NULL
cycles	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
amplification	NULL
is	NULL
in	NULL
the	NULL
linear	NULL
phase	NULL
,	NULL
because	NULL
the	NULL
level	NULL
of	NULL
amplification	NULL
of	NULL
this	NULL
gene	NULL
reaches	NULL
a	NULL
plateau	NULL
effect	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
for	NULL
TCL-1	NULL
.	NULL

Results	NULL
obtained	NULL
at	NULL
15	NULL
cycles	NULL
(	NULL
linear	NULL
phase	NULL
)	NULL
for	NULL
the	NULL
housekeeping	NULL
B-actin	NULL
gene	NULL
also	NULL
confirmed	NULL
the	NULL
data	NULL
of	NULL
amplification	NULL
observed	NULL
for	NULL
TCL1	NULL
primers	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

We	NULL
then	NULL
conducted	NULL
immunostaining	NULL
of	NULL
T-cell-enriched	NULL
PBLs	NULL
from	NULL
AT94-1	NULL
and	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
TCL1	NULL
recombinant	NULL
protein	NULL
.	NULL
``	NULL

After	NULL
enrichment	NULL
on	NULL
a	NULL
nylon-wool	NULL
column	NULL
,	NULL
77	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
of	NULL
T-cell	NULL
origin	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
staining	NULL
with	NULL
an	NULL
anti-CD7	NULL
monoclonal	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
2362	NULL
Cytospins	NULL
of	NULL
the	NULL
two	NULL
samples	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
anti-TCL1	NULL
antiserum	NULL
;	NULL
27	NULL
%	NULL
of	NULL
the	NULL
AT94-1	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
cells	NULL
showed	NULL
a	NULL
strong	NULL
cytoplasmic	NULL
signal	NULL
for	NULL
the	NULL
TCL1	NULL
protein	NULL
,	NULL
whereas	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
T-cell-enriched	NULL
population	NULL
from	NULL
the	NULL
normal	NULL
donor	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
showed	NULL
positive	NULL
signals	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
cytospins	NULL
of	NULL
unfractioned	NULL
PBLs	NULL
from	NULL
another	NULL
AT	NULL
patient	NULL
;	NULL
only	NULL
0.8	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
stained	NULL
positive	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
overexpression	NULL
of	NULL
the	NULL
TCL1	NULL
protein	NULL
in	NULL
cells	NULL
carrying	NULL
translocated	NULL
TCL1	NULL
.	NULL

The	NULL
discrepancy	NULL
between	NULL
the	NULL
data	NULL
obtained	NULL
by	NULL
immunostaining	NULL
(	NULL
27	NULL
%	NULL
of	NULL
cells	NULL
overexpressing	NULL
TCL1	NULL
)	NULL
and	NULL
the	NULL
cytogenetic	NULL
data	NULL
[	NULL
60	NULL
%	NULL
of	NULL
metaphases	NULL
with	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
]	NULL
could	NULL
reflect	NULL
either	NULL
the	NULL
lower	NULL
sensitivity	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NARDUCCI	NULL
ET	NULL
AL	NULL
Fig	NULL
3	NULL
.	NULL

Cytospins	NULL
of	NULL
T-cell-enriched	NULL
PBLs	NULL
from	NULL
AT94-1	NULL
(	NULL
A	NULL
)	NULL
and	NULL
from	NULL
a	NULL
normal	NULL
healthy	NULL
control	NULL
(	NULL
B	NULL
)	NULL
immunostained	NULL
with	NULL
polyclonal	NULL
anti-TCL1	NULL
antiserum	NULL
.	NULL

of	NULL
the	NULL
antibody	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
a	NULL
more	NULL
mitogenic	NULL
responsiveness	NULL
of	NULL
the	NULL
clonal	NULL
cell	NULL
population	NULL
to	NULL
PHA	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
in	NULL
this	NULL
disease	NULL
T	NULL
cells	NULL
may	NULL
not	NULL
respond	NULL
very	NULL
well	NULL
to	NULL
PHA	NULL
;	NULL
for	NULL
this	NULL
reason	NULL
it	NULL
could	NULL
be	NULL
possible	NULL
that	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
cells	NULL
divide	NULL
more	NULL
frequent	NULL
after	NULL
a	NULL
mitogenic	NULL
stimulus	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
explanations	NULL
could	NULL
account	NULL
for	NULL
protein	NULL
expression	NULL
results	NULL
in	NULL
AT94-1	NULL
lymphocytes	NULL
.	NULL

DISCUSSION	NULL
AT	NULL
represents	NULL
a	NULL
human	NULL
model	NULL
of	NULL
a	NULL
genetic	NULL
disease	NULL
leading	NULL
to	NULL
T-cell	NULL
leukemia	NULL
;	NULL
because	NULL
of	NULL
the	NULL
underlying	NULL
genetic	NULL
defect	NULL
in	NULL
these	NULL
patients	NULL
,	NULL
there	NULL
is	NULL
a	NULL
tendency	NULL
for	NULL
VDJ	NULL
joining	NULL
mis-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TCL1	NULL
ACTIVATION	NULL
IN	NULL
PRELEUKEMIC	NULL
T	NULL
CELLS	NULL
takes	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
chromosomal	NULL
translocations	NULL
with	NULL
the	NULL
TCR	NULL
loci	NULL
to	NULL
the	NULL
TCL1	NULL
locus	NULL
``	NULL
or	NULL
to	NULL
the	NULL
MTCP-1/	NULL
C6.1b	NULL
locus	NULL
.	NULL
``	NULL

Because	NULL
these	NULL
patients	NULL
are	NULL
routinely	NULL
checked	NULL
for	NULL
chromosomal	NULL
abnormalities	NULL
,	NULL
various	NULL
examples	NULL
of	NULL
clonal	NULL
expansions	NULL
with	NULL
a	NULL
premalignant	NULL
phenotype	NULL
have	NULL
been	NULL
widely	NULL
reported	NULL
in	NULL
the	NULL
literature	NULL
.	NULL
``	NULL

These	NULL
clones	NULL
are	NULL
invariably	NULL
associated	NULL
with	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
,	NULL
t	NULL
(	NULL
X	NULL
;	NULL
14	NULL
)	NULL
,	NULL
or	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
chromosome	NULL
translocations	NULL
or	NULL
inversions	NULL
and	NULL
expand	NULL
over	NULL
time	NULL
to	NULL
represent	NULL
up	NULL
to	NULL
100	NULL
%	NULL
of	NULL
the	NULL
T-cell	NULL
population	NULL
.	NULL

These	NULL
preleukemic	NULL
cells	NULL
consistently	NULL
progress	NULL
to	NULL
a	NULL
overt	NULL
leukemic	NULL
stage	NULL
that	NULL
usually	NULL
resembles	NULL
the	NULL
one	NULL
observed	NULL
in	NULL
T-PLL	NULL
.	NULL
'	NULL

''	NULL
*	NULL
'	NULL
Taking	NULL
advantage	NULL
of	NULL
the	NULL
recent	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
TCL1	NULL
is	NULL
overexpressed	NULL
at	NULL
the	NULL
RNA	NULL
and	NULL
protein	NULL
level	NULL
in	NULL
one	NULL
case	NULL
of	NULL
AT	NULL
bearing	NULL
60	NULL
%	NULL
of	NULL
clonal	NULL
T	NULL
cells	NULL
with	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
ql1l1.q32.1	NULL
)	NULL
with	NULL
the	NULL
breakpoint	NULL
in	NULL
the	NULL
TCL1	NULL
locus	NULL
compared	NULL
with	NULL
other	NULL
AT	NULL
cases	NULL
and	NULL
normal	NULL
healthy	NULL
individuals	NULL
without	NULL
apparent	NULL
clonal	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
a	NULL
pivotal	NULL
role	NULL
for	NULL
TCL	NULL
1	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
malignant	NULL
transformation	NULL
of	NULL
these	NULL
T-cell	NULL
leukemias	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
translocation	NULL
event	NULL
,	NULL
regulatory	NULL
elements	NULL
,	NULL
such	NULL
as	NULL
enhancers	NULL
of	NULL
the	NULL
TCRa	NULL
gene	NULL
,	NULL
move	NULL
in	NULL
proximity	NULL
of	NULL
the	NULL
TCL1	NULL
gene	NULL
,	NULL
probably	NULL
dysregulating	NULL
its	NULL
ex-pression	NULL
.	NULL

It	NULL
seems	NULL
that	NULL
TCL1	NULL
deregulation	NULL
confers	NULL
a	NULL
prolifer-ative	NULL
advantage	NULL
to	NULL
T	NULL
cells	NULL
;	NULL
whether	NULL
this	NULL
is	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
cell	NULL
survival	NULL
or	NULL
to	NULL
a	NULL
mitogenic	NULL
stimulus	NULL
is	NULL
currently	NULL
under	NULL
investigation	NULL
and	NULL
will	NULL
remain	NULL
unknown	NULL
until	NULL
the	NULL
function	NULL
of	NULL
this	NULL
gene	NULL
is	NULL
ascertained	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
TCL1	NULL
product	NULL
acts	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
T-cell	NULL
expansion	NULL
.	NULL

This	NULL
situation	NULL
can	NULL
last	NULL
for	NULL
many	NULL
years	NULL
,	NULL
and	NULL
additional	NULL
changes	NULL
may	NULL
be	NULL
required	NULL
for	NULL
a	NULL
full	NULL
malignant	NULL
transformation	NULL
.	NULL

This	NULL
last	NULL
situation	NULL
is	NULL
apparent	NULL
in	NULL
vivo	NULL
in	NULL
T-PLLs	NULL
in	NULL
which	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
or	NULL
the	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
inversions	NULL
are	NULL
involved	NULL
in	NULL
75	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
and	NULL
in	NULL
which	NULL
other	NULL
cytogenetically	NULL
abnormalities	NULL
,	NULL
such	NULL
as	NULL
iso	NULL
8q	NULL
or	NULL
iso	NULL
20	NULL
,	NULL
are	NULL
also	NULL
consistently	NULL
pres-ent	NULL
.	NULL
``	NULL

These	NULL
other	NULL
rearrangements	NULL
or	NULL
other	NULL
genetic	NULL
events	NULL
could	NULL
play	NULL
a	NULL
secondary	NULL
role	NULL
in	NULL
tumor	NULL
progression	NULL
.	NULL

Sherrington	NULL
et	NULL
al	NULL
``	NULL
have	NULL
recently	NULL
studied	NULL
similar	NULL
cases	NULL
of	NULL
clonal	NULL
expansion	NULL
in	NULL
two	NULL
cases	NULL
carrying	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
and	NULL
a	NULL
t	NULL
(	NULL
X	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
.	NULL

By	NULL
means	NULL
of	NULL
densitometric	NULL
studies	NULL
on	NULL
serial	NULL
samples	NULL
using	NULL
probes	NULL
detecting	NULL
a	NULL
rearrangement	NULL
band	NULL
at	NULL
the	NULL
TCL1	NULL
locus	NULL
and	NULL
the	NULL
TCR	NULL
B-locus	NULL
,	NULL
they	NULL
have	NULL
shown	NULL
that	NULL
cells	NULL
containing	NULL
the	NULL
translocation	NULL
are	NULL
oligoclonal	NULL
with	NULL
respect	NULL
to	NULL
in	NULL
the	NULL
preleukemic	NULL
stage	NULL
and	NULL
B-clonality	NULL
was	NULL
established	NULL
at	NULL
the	NULL
time	NULL
of	NULL
the	NULL
leukemia	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
have	NULL
not	NULL
analyzed	NULL
this	NULL
aspect	NULL
,	NULL
but	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
other	NULL
small	NULL
clones	NULL
at	NULL
cytogenetic	NULL
analysis	NULL
could	NULL
suggest	NULL
the	NULL
possibility	NULL
of	NULL
different	NULL
oligoclonal	NULL
populations	NULL
within	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
clone	NULL
,	NULL
indicating	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
these	NULL
investigators	NULL
,	NULL
that	NULL
rearrangements	NULL
at	NULL
the	NULL
TCL1	NULL
locus	NULL
can	NULL
occur	NULL
at	NULL
a	NULL
very	NULL
early	NULL
stage	NULL
during	NULL
ontogeny	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
also	NULL
substained	NULL
by	NULL
the	NULL
presence	NULL
,	NULL
near	NULL
the	NULL
breakpoint	NULL
of	NULL
molecularly	NULL
cloned	NULL
cases	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
``	NULL
of	NULL
elements	NULL
such	NULL
as	NULL
heptamer-nonamer	NULL
sequences	NULL
and	NULL
of	NULL
N-region	NULL
,	NULL
indicating	NULL
that	NULL
such	NULL
events	NULL
may	NULL
take	NULL
place	NULL
during	NULL
VDJ	NULL
rearrengement	NULL
of	NULL
T-cell	NULL
receptor	NULL
genes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
in	NULL
the	NULL
literature	NULL
that	NULL
at	NULL
least	NULL
10	NULL
%	NULL
of	NULL
these	NULL
patients	NULL
will	NULL
,	NULL
over	NULL
time	NULL
,	NULL
develop	NULL
a	NULL
clonal	NULL
T-cell	NULL
population	NULL
in	NULL
their	NULL
peripheral	NULL
blood	NULL
that	NULL
can	NULL
comprise	NULL
100	NULL
%	NULL
2363	NULL
of	NULL
the	NULL
peripheral	NULL
T-cell	NULL
metaphases	NULL
karyotypically	NULL
analyzed	NULL
.	NULL

Availability	NULL
of	NULL
antibodies	NULL
and	NULL
molecular	NULL
diagnostics	NULL
based	NULL
on	NULL
TCL1	NULL
RT-PCR	NULL
could	NULL
help	NULL
to	NULL
detect	NULL
and	NULL
to	NULL
monitor	NULL
these	NULL
leukemias	NULL
from	NULL
their	NULL
early	NULL
stages	NULL
.	NULL

These	NULL
data	NULL
also	NULL
raise	NULL
the	NULL
possibility	NULL
of	NULL
alternative	NULL
approaches	NULL
for	NULL
treating	NULL
these	NULL
early	NULL
stages	NULL
in	NULL
AT	NULL
patients	NULL
that	NULL
,	NULL
as	NULL
is	NULL
widely	NULL
known	NULL
,	NULL
are	NULL
particularly	NULL
difficult	NULL
to	NULL
treat	NULL
using	NULL
conventional	NULL
cytostatic	NULL
therapy	NULL
.	NULL

Innovative	NULL
therapies	NULL
aimed	NULL
at	NULL
the	NULL
TCL1	NULL
gene	NULL
or	NULL
at	NULL
its	NULL
product	NULL
may	NULL
result	NULL
in	NULL
the	NULL
purging	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Concetta	NULL
Barbieri	NULL
for	NULL
referring	NULL
the	NULL
AT94-1	NULL
case	NULL
,	NULL
Kay	NULL
Huebner	NULL
and	NULL
Steve	NULL
Schichman	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
Concetta	NULL
De	NULL
Paola	NULL
for	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Schwechheimer	NULL
K	NULL
,	NULL
Cavenee	NULL
WK	NULL
:	NULL
Genetics	NULL
of	NULL
cancer	NULL
predisposition	NULL
and	NULL
progression	NULL
.	NULL

Clin	NULL
Invest	NULL
71:488	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Croce	NULL
CM	NULL
:	NULL
Role	NULL
of	NULL
chromosome	NULL
translocations	NULL
in	NULL
human	NULL
neoplasia	NULL
.	NULL

Cell	NULL
49:155	NULL
,	NULL
1987	NULL
3	NULL
.	NULL

Rabbits	NULL
TH	NULL
:	NULL
Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Nature	NULL
372:143	NULL
,	NULL
1994	NULL
4	NULL
.	NULL

Pegoraro	NULL
L	NULL
,	NULL
Palumbo	NULL
A	NULL
,	NULL
Erikson	NULL
J	NULL
,	NULL
Falda	NULL
M	NULL
,	NULL
Giovanazzo	NULL
B	NULL
,	NULL
Emanuel	NULL
BS	NULL
,	NULL
Rovera	NULL
G	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
A	NULL
14	NULL
;	NULL
18	NULL
and	NULL
an	NULL
8	NULL
;	NULL
14	NULL
chromosome	NULL
translocation	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
an	NULL
acute	NULL
B-cell	NULL
leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
81:7166	NULL
,	NULL
1984	NULL
5	NULL
.	NULL

Gauwerky	NULL
CE	NULL
,	NULL
Haluska	NULL
FG	NULL
,	NULL
Tsujimoto	NULL
Y	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Evolution	NULL
of	NULL
B-cell	NULL
malignancy	NULL
:	NULL
Pre-B-cell	NULL
leukemia	NULL
resulting	NULL
from	NULL
MYC	NULL
activation	NULL
in	NULL
a	NULL
B-cell	NULL
neoplasm	NULL
with	NULL
a	NULL
rearranged	NULL
BCL2	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:8548	NULL
,	NULL
1988	NULL
6	NULL
.	NULL

Feinstein	NULL
E	NULL
,	NULL
Cimino	NULL
G	NULL
,	NULL
Gale	NULL
RP	NULL
,	NULL
Alimena	NULL
G	NULL
,	NULL
Berthier	NULL
R	NULL
,	NULL
Kishi	NULL
K	NULL
,	NULL
Goldman	NULL
J	NULL
,	NULL
Zaccaria	NULL
A	NULL
,	NULL
Berrebi	NULL
A	NULL
,	NULL
Canaani	NULL
E	NULL
:	NULL
p53	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
in	NULL
acute	NULL
phase	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:6293	NULL
,	NULL
1991	NULL
7	NULL
.	NULL

Gatti	NULL
RA	NULL
,	NULL
Mc	NULL
Conville	NULL
CM	NULL
,	NULL
Taylor	NULL
AMR	NULL
:	NULL
Sixth	NULL
International	NULL
Workshop	NULL
on	NULL
Ataxia	NULL
Telangiectasia	NULL
.	NULL

Cancer	NULL
Res	NULL
54:6007	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Kirsh	NULL
IR	NULL
:	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombination	NULL
and	NULL
ataxia	NULL
telangiectasia	NULL
:	NULL
A	NULL
review	NULL
.	NULL

Int	NULL
J	NULL
Radiat	NULL
Biol	NULL
66:897	NULL
,	NULL
1994	NULL
9	NULL
.	NULL

Lipkowitz	NULL
S	NULL
,	NULL
Stern	NULL
MH	NULL
,	NULL
Kirsh	NULL
IR	NULL
:	NULL
Hybrid	NULL
T-cell	NULL
receptor	NULL
genes	NULL
formed	NULL
by	NULL
interlocus	NULL
recombination	NULL
in	NULL
normal	NULL
and	NULL
ataxia-telangiectasia	NULL
lymphocytes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:409	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

Taylor	NULL
AMR	NULL
,	NULL
Butterworth	NULL
SV	NULL
:	NULL
Clonal	NULL
evolution	NULL
of	NULL
T	NULL
cell	NULL
lymphocytic	NULL
leukemia	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
ataxia	NULL
telangiectasia	NULL
,	NULL
Int	NULL
J	NULL
Cancer	NULL
37:511	NULL
,	NULL
1986	NULL
11	NULL
.	NULL

Russo	NULL
G	NULL
,	NULL
Isobe	NULL
M	NULL
,	NULL
Gatti	NULL
R	NULL
,	NULL
Finan	NULL
J	NULL
,	NULL
Batuman	NULL
O	NULL
,	NULL
Hubner	NULL
K	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
a	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
chromosome	NULL
translocation	NULL
in	NULL
T	NULL
cells	NULL
of	NULL
an	NULL
ataxia	NULL
telangiectasia	NULL
patient	NULL
who	NULL
developed	NULL
T	NULL
cell	NULL
leukemia	NULL
:	NULL
A	NULL
model	NULL
of	NULL
T	NULL
cell	NULL
leukemogen-esis	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:602	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Sherrington	NULL
PD	NULL
,	NULL
Fish	NULL
P	NULL
,	NULL
Taylor	NULL
AMR	NULL
,	NULL
Rabbits	NULL
TH	NULL
:	NULL
Clonal	NULL
evolution	NULL
of	NULL
malignant	NULL
and	NULL
non	NULL
malignant	NULL
T-cells	NULL
carrying	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
and	NULL
t	NULL
(	NULL
X	NULL
;	NULL
14	NULL
)	NULL
in	NULL
patients	NULL
with	NULL
atxia-telangiectasia	NULL
.	NULL

Oncogene	NULL
9:2377	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Virgilio	NULL
L	NULL
,	NULL
Narducci	NULL
MG	NULL
,	NULL
Isobe	NULL
M	NULL
,	NULL
Billips	NULL
L	NULL
,	NULL
Cooper	NULL
M	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Russo	NULL
G	NULL
:	NULL
Identification	NULL
of	NULL
the	NULL
lymphocyte-specific	NULL
TCL1	NULL
gene	NULL
involved	NULL
in	NULL
T-cell	NULL
malignancies	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:12530	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Stem	NULL
MH	NULL
,	NULL
Soulier	NULL
J	NULL
,	NULL
Rosenzwaig	NULL
M	NULL
,	NULL
Nakahara	NULL
K	NULL
,	NULL
Canki-Klain	NULL
N	NULL
,	NULL
Aurias	NULL
A	NULL
,	NULL
Sigaux	NULL
F	NULL
,	NULL
Kirsh	NULL
IR	NULL
:	NULL
MTCP-1	NULL
gene	NULL
:	NULL
A	NULL
novel	NULL
gene	NULL
on	NULL
the	NULL
human	NULL
chromosome	NULL
Xq28	NULL
translocated	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
«	NULL
/6	NULL
locus	NULL
in	NULL
mature	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Oncogene	NULL
8:2475	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2364	NULL
15	NULL
.	NULL

Fu	NULL
T	NULL
,	NULL
Virgilio	NULL
L	NULL
,	NULL
Narducci	NULL
MG	NULL
,	NULL
Facchiano	NULL
A	NULL
,	NULL
Russo	NULL
G	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Characterization	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
TCL-1	NULL
oncogene	NULL
prod-uct	NULL
.	NULL

Cancer	NULL
Res	NULL
54:6297	NULL
,	NULL
1994	NULL
16	NULL
.	NULL

Matutes	NULL
E	NULL
,	NULL
Brito-Bapapulle	NULL
V	NULL
,	NULL
Swansbury	NULL
J	NULL
,	NULL
Ellis	NULL
J	NULL
,	NULL
Morilla	NULL
R	NULL
,	NULL
Dearden	NULL
C	NULL
,	NULL
Sempere	NULL
A	NULL
,	NULL
Catovsky	NULL
D	NULL
:	NULL
Clinical	NULL
and	NULL
laboratory	NULL
features	NULL
of	NULL
78	NULL
cases	NULL
of	NULL
T-prolymphocytic	NULL
leukemia	NULL
.	NULL

Blood	NULL
78:3269	NULL
,	NULL
1991	NULL
17	NULL
.	NULL

Stern	NULL
MH	NULL
,	NULL
Theodorou	NULL
I	NULL
,	NULL
Aurias	NULL
A	NULL
,	NULL
Maier-Redelsperger	NULL
M	NULL
,	NULL
Debre	NULL
M	NULL
,	NULL
Debre	NULL
P	NULL
,	NULL
Griscelli	NULL
C	NULL
:	NULL
T-cell	NULL
non	NULL
malignant	NULL
clonal	NULL
proliferation	NULL
in	NULL
ataxia	NULL
telangiectasia	NULL
:	NULL
A	NULL
cytological	NULL
,	NULL
immunological	NULL
and	NULL
clinical	NULL
characterization	NULL
.	NULL

Blood	NULL
73:1285	NULL
,	NULL
1989	NULL
17a	NULL
.	NULL

Petrinelli	NULL
P	NULL
,	NULL
Elli	NULL
R	NULL
,	NULL
Marcucci	NULL
I	NULL
,	NULL
Barbieri	NULL
C	NULL
,	NULL
Ambra	NULL
R	NULL
,	NULL
Anto-nelli	NULL
A	NULL
;	NULL
Vp16	NULL
hypersensitivity	NULL
and	NULL
increased	NULL
faulty	NULL
recombination	NULL
in	NULL
ataxia	NULL
telangiectasia	NULL
lymphocytes	NULL
characterized	NULL
by	NULL
the	NULL
tandem	NULL
translocation	NULL
t	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q11	NULL
;	NULL
q32	NULL
)	NULL
.	NULL

Carcinogenesis	NULL
(	NULL
in	NULL
press	NULL
)	NULL
18	NULL
.	NULL

Virgilio	NULL
L	NULL
,	NULL
Isobe	NULL
M	NULL
,	NULL
Narducci	NULL
MG	NULL
,	NULL
Carotenuto	NULL
P	NULL
,	NULL
Camerini	NULL
B	NULL
,	NULL
Kurosawa	NULL
N	NULL
,	NULL
ar-Rushdi	NULL
A	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Russo	NULL
G	NULL
:	NULL
Chromosome	NULL
walking	NULL
on	NULL
the	NULL
TCL1	NULL
locus	NULL
involved	NULL
in	NULL
T-cell	NULL
neoplasia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:9275	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Russo	NULL
G	NULL
,	NULL
Isobe	NULL
M	NULL
,	NULL
Pegoraro	NULL
L	NULL
,	NULL
Finan	NULL
J	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
a	NULL
t	NULL
(	NULL
7	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q35	NULL
;	NULL
q32	NULL
)	NULL
chromosome	NULL
translocation	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
leukemia	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
ataxia	NULL
telangiectasia	NULL
.	NULL

Cell	NULL
53:137	NULL
,	NULL
1988	NULL
20	NULL
.	NULL

Johnson	NULL
JP	NULL
,	NULL
Gatti	NULL
RA	NULL
,	NULL
Sears	NULL
TS	NULL
,	NULL
White	NULL
RL	NULL
:	NULL
Inverted	NULL
duplication	NULL
of	NULL
JH	NULL
associated	NULL
with	NULL
chromosome	NULL
14	NULL
translocation	NULL
and	NULL
T-cell	NULL
leukemia	NULL
in	NULL
ataxia-telangiectasia	NULL
.	NULL

Am	NULL
J	NULL
Hum	NULL
Genet	NULL
39:787	NULL
,	NULL
1986	NULL
21	NULL
.	NULL

Aurias	NULL
A	NULL
,	NULL
Croquette	NULL
MF	NULL
,	NULL
Nuyts	NULL
JP	NULL
,	NULL
Griscelli	NULL
C	NULL
,	NULL
Dutrillax	NULL
B	NULL
:	NULL
NARDUCCI	NULL
ET	NULL
AL	NULL
New	NULL
data	NULL
on	NULL
clonal	NULL
anomalies	NULL
of	NULL
chromosome	NULL
14	NULL
in	NULL
ataxia	NULL
telangiectasia	NULL
:	NULL
tct	NULL
(	NULL
14	NULL
;	NULL
14	NULL
)	NULL
and	NULL
inv	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Hum	NULL
Genet	NULL
72:22	NULL
,	NULL
1986	NULL
22	NULL
.	NULL

Jonasson	NULL
JA	NULL
:	NULL
Analysis	NULL
and	NULL
interpretation	NULL
of	NULL
human	NULL
chro-mosme	NULL
preparations	NULL
,	NULL
in	NULL
Rooney	NULL
DE	NULL
,	NULL
Czepulkowski	NULL
BH	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
;	NULL
Human	NULL
Cytogenetics	NULL
:	NULL
A	NULL
Practical	NULL
Approach	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
IRL	NULL
,	NULL
1986	NULL
,	NULL
p	NULL
85	NULL
23	NULL
.	NULL

Davey	NULL
MP	NULL
,	NULL
BertnessV	NULL
,	NULL
Nakahara	NULL
K	NULL
,	NULL
Johnson	NULL
JP	NULL
,	NULL
Mc	NULL
Bride	NULL
OW	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Kirsh	NULL
IK	NULL
:	NULL
Juxtaposition	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
alpha	NULL
chain	NULL
locus	NULL
(	NULL
14g11	NULL
)	NULL
and	NULL
a	NULL
region	NULL
(	NULL
14q32	NULL
)	NULL
of	NULL
potential	NULL
importance	NULL
in	NULL
leukemogenesis	NULL
by	NULL
a	NULL
14	NULL
;	NULL
14	NULL
translocation	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
T-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
ataxia	NULL
telangiectasia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:9287	NULL
,	NULL
1988	NULL
24	NULL
.	NULL

Mengle-Gaw	NULL
L	NULL
,	NULL
Albertson	NULL
DG	NULL
,	NULL
Sherrington	NULL
P	NULL
,	NULL
Rabbits	NULL
TH	NULL
:	NULL
Analysis	NULL
of	NULL
a	NULL
T-cell	NULL
tumor-specific	NULL
breakpoint	NULL
cluster	NULL
at	NULL
human	NULL
chromosome	NULL
14g32	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:9171	NULL
,	NULL
1988	NULL
25	NULL
.	NULL

Fish	NULL
P	NULL
,	NULL
Forster	NULL
A	NULL
,	NULL
Sherrington	NULL
PD	NULL
,	NULL
Dyer	NULL
MJS	NULL
,	NULL
Rabbits	NULL
TH	NULL
:	NULL
The	NULL
chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
X	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q28	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
T-cell	NULL
prolymphocytic	NULL
leukemia	NULL
breaks	NULL
within	NULL
one	NULL
gene	NULL
and	NULL
activates	NULL
another	NULL
.	NULL

Oncogene	NULL
8:3271	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Thick	NULL
J	NULL
,	NULL
Mak	NULL
YF	NULL
,	NULL
Metcalfe	NULL
J	NULL
,	NULL
Beatty	NULL
D	NULL
,	NULL
Taylor	NULL
AMR	NULL
:	NULL
A	NULL
gene	NULL
on	NULL
chromosome	NULL
Xq28	NULL
associated	NULL
wiyh	NULL
T-cell	NULL
prolymphocytic	NULL
leukemia	NULL
in	NULL
two	NULL
patients	NULL
with	NULL
ataxia-telangiactasia	NULL
,	NULL
Leukemia	NULL
8:564	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

Brito	NULL
Babapulle	NULL
V	NULL
,	NULL
Catovsky	NULL
D	NULL
:	NULL
Inversion	NULL
and	NULL
tandem	NULL
duplication	NULL
involving	NULL
chromosome	NULL
14q11	NULL
and	NULL
14q32	NULL
in	NULL
T-prolymphocytic	NULL
leukemia	NULL
in	NULL
patients	NULL
with	NULL
ataxia-telangiectasia	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cyto-genet	NULL
55:1	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
86	NULL
:	NULL
2358-2364	NULL
TCL1	NULL
oncogene	NULL
activation	NULL
in	NULL
preleukemic	NULL
T	NULL
cells	NULL
from	NULL
a	NULL
case	NULL
of	NULL
ataxia-	NULL
telangiectasia	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
MG	NULL
Narducci	NULL
,	NULL
L	NULL
Virgilio	NULL
,	NULL
M	NULL
Isobe	NULL
,	NULL
A	NULL
Stoppacciaro	NULL
,	NULL
R	NULL
Elli	NULL
,	NULL
M	NULL
Fiorilli	NULL
,	NULL
M	NULL
Carbonari	NULL
,	NULL
A	NULL
Antonelli	NULL
,	NULL
L	NULL
Chessa	NULL
,	NULL
CM	NULL
Croce	NULL
and	NULL
G	NULL
Russo	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/6/2358.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

